RxSight Inc. (RXST)
NASDAQ · Healthcare
RxSight Inc. EBITDA 2020–2025
RxSight Inc. annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- RxSight Inc. ebitda for the quarter ending March 31, 2026 was -17.0 M, a 71.70% increase year-over-year.
- RxSight Inc. ebitda for the twelve months ending March 31, 2026 was -48.6 M.
- RxSight Inc. annual ebitda for 2025 was -44.9 M, a 34.98% increase from 2024.
- RxSight Inc. annual ebitda for 2024 was -33.3 M, a 27.66% decrease from 2023.
- RxSight Inc. annual ebitda for 2023 was -46.0 M, a 22.59% decrease from 2022.
- RxSight Inc. annual ebitda for 2022 was -59.4 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
RxSight Inc. EBITDA — FAQ
RxSight Inc. (RXST) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RXST's ebitda history?
The chart and table above show RxSight Inc.'s ebitda by year and by quarter, including the growth rate.